Understanding the mechanisms of aneuploid cell elimination during early mammalian development
Understanding the mechanisms of aneuploid cell elimination during early mammalian development
批准号:
BB/S008284/1
负责人:
Tristan Rodriguez
金额:
$69.19万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
During early development errors in cell division causes the daughter cells to have either fewer or extra numbers of chromosomes. This condition is called aneuploidy and is highly detrimental to embryogenesis. During development, aneuploid cells are normally removed from the embryo by the quality control mechanisms that ensure tissue fitness. When this is not possible aneuploidy causes miscarriage. However, in spite of aneuploidy being the leading cause of spontaneous pregnancy loss in humans, we still know surprisingly little about the consequences of chromosomal abnormalities during embryonic development.In this proposal we aim to identify what happens to aneuploid cells during early mammalian development. For this we will do three things:First, we will analyse which are the most important properties of aneuploid cells during early embryo development. To achieve this, we will use the mouse embryo as our model system as its early development recapitulates many features of human development. Using this system, we will artificially induce aneuploidy in cells and embryos and analyse what types of stress pathways are activated in these cells. Once the specific stress pathways that are induced by aneuploidy are identified, these will manipulated to test if activation reproduces the adverse effects of aneuploidy. We will also test if inhibiting these stresses prevents aneuploid cell elimination in the embryo.The second thing that we will do to study what happens to aneuploid cells during development is to analyse what signals are activated by aneuploidy induced stress and cause the death of aneuploid cells and embryos. Our previous work has identified the mTOR pathway, that is a key regulator of cell growth, as important for the elimination of abnormal cells during embryonic development. Here we will test the importance of the mTOR pathway for the elimination of aneuploid cells by asking how its repression prevents aneuploid cell propagation.The third thing that we will do to study aneuploidy during embryogenesis is to analyse exactly when aneuploid cells are eliminated during embryo development. For this we will study the levels of aneuploidy at different stages of mouse embryogenesis.Together we anticipate that our studies will provide a comprehensive overview of what the fate of aneuploidy is in the embryo and what are the adverse effects of aneuploidy.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1242/dev.202503
发表时间:
2024-01-15
期刊:
Development (Cambridge, England)
影响因子:
--
作者:
[]
通讯作者:
Cell Competition: A Choreographed Dance of Death.
细胞竞赛:精心设计的死亡之舞。
DOI:
10.1016/j.cub.2021.01.017
发表时间:
2021
期刊:
CB
影响因子:
--
作者:
[Lima A]
通讯作者:
Lima A
DOI:
10.1101/gad.347542.120
发表时间:
2021-04-01
期刊:
Genes & development
影响因子:
10.5
作者:
[Pilley S, Rodriguez TA, Vousden KH]
通讯作者:
Vousden KH
DOI:
10.1038/s42255-021-00422-7
发表时间:
2021-08
期刊:
Nature metabolism
影响因子:
20.8
作者:
[Lima A, Lubatti G, Burgstaller J, Hu D, Green AP, Di Gregorio A, Zawadzki T, Pernaute B, Mahammadov E, Perez-Montero S, Dore M, Sanchez JM, Bowling S, Sancho M, Kolbe T, Karimi MM, Carling D, Jones N, Srinivas S, Scialdone A, Rodriguez TA]
通讯作者:
Rodriguez TA
DOI:
10.1016/j.devcel.2022.04.020
发表时间:
2022-06-06
期刊:
DEVELOPMENTAL CELL
影响因子:
11.8
作者:
[Pernaute, Barbara, Perez-Montero, Salvador, Nieto, Juan Miguel Sanchez, Di Gregorio, Aida, Lima, Ana, Lawlor, Katerina, Bowling, Sarah, Liccardi, Gianmaria, Tomas, Alejandra, Meier, Pascal, Sesaki, Hiromi, Rutter, Guy A., Barbaric, Ivana, Rodriguez, Tristan A.]
通讯作者:
Rodriguez, Tristan A.
Unravelling the pathways that mediate cell competition during embryonic differentiation
-
批准号:BB/W016079/1
-
项目类别:Research Grant
-
资助金额:$67.49万
-
财政年份:2023
-
负责人:Tristan Rodriguez
-
依托单位:
Mechanisms of selection against cells with mitochondrial dysfunction during mammalian development
-
批准号:MR/W02425X/1
-
项目类别:Research Grant
-
资助金额:$102.64万
-
财政年份:2022
-
负责人:Tristan Rodriguez
-
依托单位:
Mechanisms regulating the timing of developmental events in the early mouse embryo
-
批准号:MR/T028637/1
-
项目类别:Research Grant
-
资助金额:$100.86万
-
财政年份:2020
-
负责人:Tristan Rodriguez
-
依托单位:
Pathways governing the competitive behaviour of pluripotent cells
-
批准号:MR/P018467/1
-
项目类别:Research Grant
-
资助金额:$80.85万
-
财政年份:2017
-
负责人:Tristan Rodriguez
-
依托单位:
Mitochondrial Dynamics in the Control of the Pluripotent States
-
批准号:MR/N009371/1
-
项目类别:Research Grant
-
资助金额:$92.25万
-
财政年份:2016
-
负责人:Tristan Rodriguez
-
依托单位:
Mechanisms of miRNA regulation of early embryonic development
-
批准号:MR/K00090X/1
-
项目类别:Research Grant
-
资助金额:$94.32万
-
财政年份:2013
-
负责人:Tristan Rodriguez
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
-
批准号:--
-
项目类别:外国学者研究基金
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI Z
-
依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
-
批准号:W2433169
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI ZHANG
-
依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
-
批准号:82371255
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:曹立
-
依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
-
批准号:82371248
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:吴逸雯
-
依托单位:
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
-
批准号:82372015
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:熊丽琴
-
依托单位:
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位: